PCR-Based Identification of Klebsiella Pneumoniae Subsp

PCR-Based Identification of Klebsiella Pneumoniae Subsp

PCR-based identification of Klebsiella pneumoniae subsp. rhinoscleromatis, the agent of rhinoscleroma. Cindy Fevre, Virginie Passet, Alexis Deletoile, Valérie Barbe, Lionel Frangeul, Ana Almeida, Philippe Sansonetti, Régis Tournebize, Sylvain Brisse To cite this version: Cindy Fevre, Virginie Passet, Alexis Deletoile, Valérie Barbe, Lionel Frangeul, et al.. PCR-based identification of Klebsiella pneumoniae subsp. rhinoscleromatis, the agent of rhinoscleroma.. PLoS Neglected Tropical Diseases, Public Library of Science, 2011, 5 (5), pp.e1052. 10.1371/jour- nal.pntd.0001052. inserm-00691408 HAL Id: inserm-00691408 https://www.hal.inserm.fr/inserm-00691408 Submitted on 26 Apr 2012 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. PCR-Based Identification of Klebsiella pneumoniae subsp. rhinoscleromatis, the Agent of Rhinoscleroma Cindy Fevre1, Virginie Passet1, Alexis Deletoile1, Vale´ rie Barbe2, Lionel Frangeul3, Ana S. Almeida4,5, Philippe Sansonetti4,5,Re´gis Tournebize4,5, Sylvain Brisse1* 1 Institut Pasteur, Genotyping of Pathogens and Public Health, Paris, France, 2 CEA-IG, Genoscope, Evry, France, 3 Institut Pasteur, Inte´gration et Analyse Ge´nomique, Paris, France, 4 Institut Pasteur, Unite´ de Pathoge´nie Microbienne Mole´culaire, Paris, France, 5 Unite´ INSERM U786, Institut Pasteur, Paris, France Abstract Rhinoscleroma is a chronic granulomatous infection of the upper airways caused by the bacterium Klebsiella pneumoniae subsp. rhinoscleromatis. The disease is endemic in tropical and subtropical areas, but its diagnosis remains difficult. As a consequence, and despite available antibiotherapy, some patients evolve advanced stages that can lead to disfiguration, severe respiratory impairment and death by anoxia. Because identification of the etiologic agent is crucial for the definitive diagnosis of the disease, the aim of this study was to develop two simple PCR assays. We took advantage of the fact that all Klebsiella pneumoniae subsp. rhinoscleromatis isolates are (i) of capsular serotype K3; and (ii) belong to a single clone with diagnostic single nucleotide polymorphisms (SNP). The complete sequence of the genomic region comprising the capsular polysaccharide synthesis (cps) gene cluster was determined. Putative functions of the 21 genes identified were consistent with the structure of the K3 antigen. The K3-specific sequence of gene Kr11509 (wzy) was exploited to set up a PCR test, which was positive for 40 K3 strains but negative when assayed on the 76 other Klebsiella capsular types. Further, to discriminate Klebsiella pneumoniae subsp. rhinoscleromatis from other K3 Klebsiella strains, a specific PCR assay was developed based on diagnostic SNPs in the phosphate porin gene phoE. This work provides rapid and simple molecular tools to confirm the diagnostic of rhinoscleroma, which should improve patient care as well as knowledge on the prevalence and epidemiology of rhinoscleroma. Citation: Fevre C, Passet V, Deletoile A, Barbe V, Frangeul L, et al. (2011) PCR-Based Identification of Klebsiella pneumoniae subsp. rhinoscleromatis, the Agent of Rhinoscleroma. PLoS Negl Trop Dis 5(5): e1052. doi:10.1371/journal.pntd.0001052 Editor: Craig R. Roy, Yale University School of Medicine, United States of America Received June 2, 2010; Accepted April 26, 2011; Published May 24, 2011 Copyright: ß 2011 Fevre et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: This work was supported financially by Institut Pasteur and the Genoscope (Evry, France), as well as by a generous gift from the Conny-Maeva Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. * E-mail: [email protected] Introduction rhinoscleromatis is strictly associated with humans and has, to our knowledge, only been isolated from cases of rhinoscleroma. As K. Rhinoscleroma is a chronic granulomatous infection of the nose pneumoniae subsp. rhinoscleromatis is not considered as a commensal and upper airways of humans. The relative rarity of the disease and of the respiratory tract, its identification is key to the definitive low specificity of early symptoms make the clinical diagnosis of diagnosis of the disease [12,13]. This infectious agent is rhinoscleroma difficult [1]. As a consequence, some patients evolve metabolically less versatile than other K. pneumoniae strains, but advanced stages that can lead to severe respiratory impairment [2]. definitive identification based on biochemical properties (ONPG The most characteristic feature of the disease is the observation in negative, no acid production from lactose, urease, LDC and citrate biopsies of big foamy cells, called Mikulicz cells, in which bacilli are negative) is rendered difficult due to variation in metabolic seen after hematoxilin-eosin staining [3]. Hence, the specific characteristics of K. pneumoniae strains [9,11]. Furthermore, diagnosis of rhinoscleroma currently relies on the combination of members of a third subspecies, K. pneumoniae subsp. ozaenae, which histological and bacteriological examinations, with the presence of are associated with an atrophic rhinitis known as ozaena, also have Mikulicz cells and the identification of the causative agent, the reduced metabolic capacities [8]. bacterium Klebsiella pneumoniae subsp. rhinoscleromatis [4] from tissue Klebsiella strains are typically surrounded by a polysaccharidic culture, nasal swabs or blood culture [4,5]. capsule of considerable thickness that is responsible for the mucoid Initially, species status (Klebsiella rhinoscleromatis) was given to the aspect of colonies. Klebsiella capsular serotyping (K typing) agent of rhinoscleroma. However, given high similarity based on distinguishes at least 77 K types [7,14]. As all strains of K. pneumoniae DNA-DNA hybridization [6], it is now regarded as a subspecies of subsp. rhinoscleromatis are of capsular type 3 (K3), K typing is used for Klebsiella pneumoniae [7]. Multiple gene sequencing confirmed the confirmatory identification of K. pneumoniae subsp. rhinoscleromatis and close relatedness of the agent of rhinoscleroma with K. pneumoniae allows distinction from K. pneumoniae subsp. ozaenae strains, which are [8–10]. Currently, the definitive identification of the organism is mostly of type K4 and more rarely of types K5 and K6 [7]. difficult. Different from K. pneumoniae sensu stricto (i.e., K. However, K typing is technically cumbersome and a small pneumoniae subsp. pneumoniae), which can be encountered in many proportion of K. pneumoniae subsp. pneumoniae strains (including the hosts, environments and clinical sources [11], K. pneumoniae subsp. type strain CIP 82.91T = ATCC 13883T) are of type K3 as well, www.plosntds.org 1 May 2011 | Volume 5 | Issue 5 | e1052 Identification of the Agent of Rhinoscleroma Author Summary Methods In humans, the bacterium Klebsiella pneumoniae subsp. Identification and sequencing of strain SB3432 rhinoscleromatis (also called clone Rhinoscleromatis, as it The clone Rhinoscleromatis strain SB3432 was isolated in 2004 evolved from a single Klebsiella pneumoniae ancestral in the Avicenne hospital, Bobigny, France from a biopsy of the left strain) causes rhinoscleroma, a chronic infection of the nasal cavity of an 11-year old patient diagnosed with rhinoscle- nose and throat. Identification of the bacterium from roma. Identification was initially achieved using API NE and biopsies or nasal secretions is essential for diagnosis, and API20E strips (BioMerieux, Marcy-l’Etoile, France), and by currently relies on the biochemical characteristics of clone biochemical characteristics [11]. MLST [16] confirmed this strain Rhinoscleromatis and on detection of its capsule of to be 100% identical at seven housekeeping genes to the type antigenic type K3. Our aim was to develop two identifi- strain of K. pneumoniae subsp. rhinoscleromatis CIP 52.210T ( = ATCC cation tests based on amplification by polymerase chain 13884T). The cps PCR-RFLP pattern was determined as C3a by reaction (PCR) of specific portions of the genome of clone the molecular serotyping method [15]. In the frame of the Rhinoscleromatis. We established the sequence of the complete genome sequencing of Rhinoscleromatis strain SB3432, capsular polysaccharide synthesis cluster and identified the cps cluster sequence was determined. The K3 cps cluster one gene sequence that was unique to K3 strains. A PCR sequence was deposited in GenBank/EMBL/DDBJ databases test that targets this gene was shown to be specific for K3 strains. We also exploited unique DNA signatures of clone under accession number FQ311478. Rhinoscleromatis to develop a second PCR test, which is specific for this clone, thus allowing distinction from other Annotation of the

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    8 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us